Your search returned 5 results.

Results
	1.	[Comparative evaluation of adverse reactions between gefitinib and erlotinib treatments in the same patients]. [electronic resource] by Ohashi, Yasukata Suzuki, Kenichi Sakurai, Michiru Shino, Michihiro Murakami, Haruyasu Takahashi, Toshiaki Yamamoto, Nobuyuki Producer: 20090929 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 36 Availability: No items available. Save to lists Add to cart (remove)
	2.	Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy and safety of combined triplet therapy and olanzapine for prevention of carboplatin-induced nausea and vomiting in gynaecological cancer patients. [electronic resource] by Iihara, Hirotoshi Shimokawa, Mototsugu Abe, Masakazu Hayasaki, Yoh Fujita, Yukiyoshi Nagasawa, Yuki Sakurai, Michiru Matsuoka, Rie Suzuki, Akio Morishige, Kenichiro Producer: 20200210 In: BMJ open vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	[Safety analysis of eight patients treated with erlotinib after severe gefitinib-induced liver injury]. [electronic resource] by Ohashi, Yasukata Suzuki, Kenichi Sakurai, Michiru Ishikawa, Hiroshi Onishi, Tomohisa Nakagaki, Shigeru Kato, Toshiaki Shino, Michihiro Naito, Tateaki Takahashi, Toshiaki Yamamoto, Nobuyuki Producer: 20100817 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 37 Availability: No items available. Save to lists Add to cart (remove)
	4.	Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study. [electronic resource] by Iihara, Hirotoshi Shimokawa, Mototsugu Hayasaki, Yoh Fujita, Yukiyoshi Abe, Masakazu Takenaka, Motoki Yamamoto, Senri Arai, Takahiro Sakurai, Michiru Mori, Minako Nakamura, Kazuto Kado, Nobuhiro Murase, Saki Shimaoka, Ryuichi Suzuki, Akio Morishige, Ken-Ichirou Producer: 20200702 In: Gynecologic oncology vol. 156 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [electronic resource] by Hashimoto, Hironobu Abe, Masakazu Tokuyama, Osamu Mizutani, Hideaki Uchitomi, Yosuke Yamaguchi, Takuhiro Hoshina, Yukari Sakata, Yasuhiko Takahashi, Takako Yanai Nakashima, Kazuhisa Nakao, Masahiko Takei, Daisuke Zenda, Sadamoto Mizukami, Koki Iwasa, Satoru Sakurai, Michiru Yamamoto, Noboru Ohe, Yuichiro Producer: 20200706 In: The Lancet. Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)